Rheumatology Education in Europe: results of a survey of young rheumatologistsBANDINELLI, F; BIJLSMA, J. W. J; MAYER, M et al.Clinical and experimental rheumatology (Testo stampato). 2011, Vol 29, Num 5, pp 843-845, issn 0392-856X, 3 p.Article

Vorgehen bei der Erstellung von EULAR-Empfehlungen : Implementation von Leitlinien: Wunsch und Wirklichkeit = The process of generating EULAR recommendations : Implementation of Guidelines: intention and realityDOUGADOS, M.Zeitschrift für Rheumatologie (Print). 2010, Vol 69, Num 4, issn 0340-1855, 305-309 [4 p.]Article

ETP et recommandations professionnelles de bonnes pratiques: Que précisent les sociétés savantes ? : Education thérapeutiqueBEAUVAIS, Catherine.Rhumatos. 2010, Vol 7, Num 58, pp 147-148, issn 1771-0081, 2 p., CAH1Article

EULAR efforts to define quality of careDOUGADOS, M.Clinical and experimental rheumatology (Testo stampato). 2007, Vol 25, Num 6, issn 0392-856X, S14-S17, SUP47Article

Agreement with Guidelines from a Large Database for Management of Systemic Sclerosis: Results from the Canadian Scleroderma Research GroupPOPE, Janet; HARDING, Sarah; KHIMDAS, Sarit et al.Journal of rheumatology. 2012, Vol 39, Num 3, pp 524-531, issn 0315-162X, 8 p.Article

Thérapie de la polyarthrite rhumatoïde: Les critères de rémission : LES ETUDES MARQUANTES DE 2011SARAUX, Alain.Rhumatos. 2012, Vol 9, Num 74, pp 14-15, issn 1771-0081, 2 p.Article

Sustained benefit in rheumatoid arthritis following one course of rituximab : improvements in physical function over 2 yearsSTRAND, V; BALBIR-GURMAN, A; PAVELKA, K et al.Rheumatology (Oxford. Print). 2006, Vol 45, Num 12, pp 1505-1513, issn 1462-0324, 9 p.Article

Évaluation du risque cardiovasculaire selon l'indice SCORE national calibré chez les patients atteints de rhumatisme psoriasique sans maladie cardiovasculaire clinique évidente ni de facteurs de risque classiques d'athéroscléroseROSALES ALEXANDER, José Luis; CANTERO-HINOJOSA, Jesús; SALVATIERRA, Juan et al.Revue du rhumatisme (Ed. française). 2014, Vol 81, Num 2, pp 154-158, issn 1169-8330, 5 p.Article

Recommandations EULAR 2009 de prise en charge de la PR: L'essentiel en 15 pointsWENDLING, Daniel.Rhumatos. 2010, Vol 7, Num 58, issn 1771-0081, p. 7, CAH3Article

Recommandations de l'EULAR pour traiter la gonarthrose. Résultats d'un groupe de travail du Comité directeur des études cliniques internationales incluant les essais thérapeutiques de l'EULAR = EULAR recommendations for the management of knee osteoarthritis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic TrialsMAZIERES, Bernard; BANNWARTH, Bernard; DOUGADOS, Maxime et al.Revue du rhumatisme (Ed. française). 2001, Vol 68, Num 5, pp 408-419, issn 1169-8330Conference Paper

Patient-reported 28 swollen and tender joint counts accurately represent RA disease activity and can be used to assess therapy responses at the group levelRIAZZOLI, Jenny; NILSSON, Jan-Ake; TELEMAN, Annika et al.Rheumatology (Oxford. Print). 2010, Vol 49, Num 11, pp 2098-2103, issn 1462-0324, 6 p.Article

Imagerie dans la polyarthrite rhumatoïde: Quel type d'érosion prendre en compte dans les critères de classification ACR/EULAR 2010 ?DEVAUCHELLE-PENSEC, Valérie.Rhumatos. 2012, Vol 9, Num 79, pp 219-220, issn 1771-0081, 2 p.Article

Late-onset systemic sclerosis-a systematic survey of the EULAR scleroderma trials and research group databaseHÜGLE, Thomas; SCHUETZ, Philipp; DAIKELER, Thomas et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 1, pp 161-165, issn 1462-0324, 5 p.Article

Rheumatoid arthritis and glucocorticoids; the contribution of a literature search to the development of a EULAR recommendation on treatment with glucocorticoids in RAGORTER, S. L.Clinical and experimental rheumatology (Testo stampato). 2011, Vol 29, Num 5, issn 0392-856X, S77-S80, SUP68Article

Comparison of the 2010 American College of Rheumatology/European League Against Rheumatism and the 1987 American Rheumatism Association Classification Criteria for Rheumatoid Arthritis in an Early Arthritis Cohort in New ZealandRAJA, Rafi; CHAPMAN, Peter T; O'DONNELL, John L et al.Journal of rheumatology. 2012, Vol 39, Num 11, pp 2098-2103, issn 0315-162X, 6 p.Article

EULAR-Empfehlungen für die Behandlung des Morbus Behçet: Bericht einer Task Force des European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) = EULAR recommendations for the management of Behçet's disease. Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)KÖTTER, I.Zeitschrift für Rheumatologie (Print). 2009, Vol 68, Num 2, issn 0340-1855, 157-161 [4 p.]Article

FCGR2A/CD32A and FCGR3A/CD16A Variants and EULAR Response to Tumor Necrosis Factor-α Blockers in Psoriatic Arthritis: A Longitudinal Study with 6 Months of FollowupRAMIREZ, Julio; FERNANDEZ-SUEIRO, Jose Luis; LOPEZ-MEJIAS, Raquel et al.Journal of rheumatology. 2012, Vol 39, Num 5, pp 1035-1041, issn 0315-162X, 7 p.Article

ACR/EULAR 2010 rheumatoid arthritis classification criteriaKAY, Jonathan; UPCHURCH, Katherine S.Rheumatology (Oxford. Print). 2012, Vol 51, issn 1462-0324, vi5-vi9, SUP6Article

ANCA-associated vasculitides: Pathogenetic aspects and current evidence-based therapyHOLLE, J. U; GROSS, W. L.Journal of autoimmunity (Print). 2009, Vol 32, Num 3-4, pp 163-171, issn 0896-8411, 9 p.Article

Syndrome de Gougerot-Sjögren: Place du rituximab dans l'arsenal thérapeutiqueRICHEZ, Christophe.Rhumatos. 2012, Vol 9, Num 79, pp 212-214, issn 1771-0081, 3 p.Article

The new ACR/EULAR remission criteria: rationale for developing new criteria for remissionBYKERK, Vivian P; MASSAROTTI, Elena M.Rheumatology (Oxford. Print). 2012, Vol 51, issn 1462-0324, vi16-vi20, SUP6Article

Polyarthrite rhumatoïde: Pathogénie, clinique et imagerie = Rheumatoid arthritis: Pathogeny, clinical and radiogical aspectsMOREL, Jacques; LOEUILLE, Damien.La Lettre du rhumatologue. 2010, Num 358, issn 0761-5027, 10-17 [6 p.]Conference Paper

Dosisanpassung bei Patienten mit rheumatoider Arthritis unter Therapie mit Infliximab in der rheumatologischen Versorgung in Deutschland : Ergebnisse aus dem Biologika-Register RABBIT = Dose adjustment in patients treated with infliximab in routine rheumatologic care in Germany. Results from the Biologies Register RABBITZINK, A; LISTING, J; STRANGFELD, A et al.Zeitschrift für Rheumatologie (Print). 2006, Vol 65, Num 5, pp 441-446, issn 0340-1855, 6 p.Article

Onset of action of etanercept in rheumatoid arthritis based on patient-reported outcomesDOUGADOS, M; RIPERT, M; HILLIQUIN, P et al.Clinical and experimental rheumatology (Testo stampato). 2012, Vol 30, Num 2, pp 266-268, issn 0392-856X, 3 p.Article

Predictors of response to rituximab in patients with active rheumatoid arthritis and inadequate response to anti-TNF agents or traditional DMARDsNARVAEZ, J; DIAZ-TORNE, C; RUIZ, J. M et al.Clinical and experimental rheumatology (Testo stampato). 2011, Vol 29, Num 6, pp 991-997, issn 0392-856X, 7 p.Article